WuXi Biologics launches drug product facility in China for pre-filled syringes 08-Jun-2022 By Jane Byrne WuXi Biologics says it has successfully launched the GMP operation of its new drug product facility, DP5, which is located in Wuxi, China.
Baxter investing $100m to bolster German sterile fill/finish facility 11-Nov-2021 By Jenni Spinner The infusion of funds in the Halle/Westfalen, Germany manufacturing complex is intended to help meet growing global demand for injectable pharmaceuticals.
RheaVita raises €2.5m, looks to disrupt the freeze-drying market 03-Jun-2021 By Jane Byrne RheaVita, a company developing continuous freeze-drying technology for biopharma products, has closed a €2.5m (US$3.04m) Series A financing round.
Innovators investing in new injectable devices to speed vaccination campaigns 10-Feb-2021 By Jane Byrne In recent months we have seen companies investing in capacity and technology around pre-fillable systems for both new injectable drugs and vaccines.
US strikes $138m deal to ensure enough syringes for COVID-19 vaccine 13-May-2020 By Ben Hargreaves US HHS provides funding in order to boost the number of prefilled syringes available for potential vaccine against coronavirus.